A single-center retrospective study conducted in Japan has revealed that combining microhook ab interno trabeculotomy with cataract surgery provides effective short-term intraocular pressure reduction in older glaucoma patients without escalating perioperative complication rates. The clinical investigation evaluated outcomes across sixty-seven consecutive eyes undergoing the combined procedure at Asao General Hospital between September 2023 and September 2024, with each participant monitored for at least six months following surgery. The findings demonstrate that elderly individuals, including very old patients with an average age exceeding eighty-two years in the upper age tier, achieved surgical success and safety profiles comparable to younger counterparts. By lowering intraocular pressure and reducing the daily requirement for topical pressure-lowering drops, this bleb-independent surgical intervention addresses a growing therapeutic challenge in aging societies worldwide, where cataracts and glaucoma frequently co-occur and complicate chronic medical management.
Glaucoma represents a principal cause of irreversible visual impairment on a global scale, exhibiting a marked increase in prevalence as populations advance in age. In rapidly aging nations such as Japan, a substantial proportion of patients diagnosed with glaucoma simultaneously develop visually significant cataracts that require surgical lens extraction. For these older individuals, therapeutic objectives extend considerably beyond numerical intraocular pressure reduction to encompass easing the burden of complex daily topical eye-drop regimens, preserving functional visual acuity, and avoiding demanding postoperative regimens. Bleb-forming filtration operations like conventional trabeculectomy frequently entail intensive postoperative management, including frequent outpatient visits and invasive interventions such as laser suture lysis, alongside vulnerabilities to late-onset bleb infections and leakage. Consequently, ophthalmologists have increasingly turned toward minimally invasive glaucoma surgeries that operate ab interno through clear corneal incisions while preserving the overlying conjunctival architecture.
Microhook ab interno trabeculotomy, commonly abbreviated as µLOT, is a trabecular meshwork- and Schlemm’s canal-based minimally invasive procedure designed to alleviate aqueous outflow resistance. Performed through a small clear corneal incision, the procedure utilizes an ophthalmic microhook to incise the trabecular meshwork and inner wall of Schlemm’s canal under direct gonioscopic visualization. Because µLOT does not rely on the creation of a subconjunctival filtration bleb, it avoids bleb-related complications and reduces postoperative monitoring demands, making it an appealing therapeutic candidate for frail older individuals managing multiple systemic comorbidities and complex medication schedules. Nevertheless, age-dependent structural alterations in ocular tissues, progressive degeneration within distal conventional outflow pathways, and concurrent systemic diseases have raised persistent questions regarding whether older adults can achieve comparable pressure control or whether they might face higher rates of post-surgical complications such as hyphema or transient pressure spikes.
To investigate these age-related clinical questions, researchers reviewed the medical records of sixty-seven patients, comprising twenty-seven men and forty women, whose mean overall age stood at 75.5 years with a distribution ranging from 54 to 90 years. Primary open-angle glaucoma represented the predominant diagnosis, accounting for fifty-three eyes or seventy-nine percent of the total cohort, while fourteen eyes presented with other glaucoma classifications, including open-angle glaucoma with an angle-closure component, exfoliation glaucoma, and uveitic glaucoma. All enrolled patients underwent standardized phacoemulsification with intraocular lens implantation followed immediately by trabeculotomy using the Shoji edition of the Tanito Microhook. The surgeon made an incision covering approximately 120 degrees within the nasal angle under gonioscopy, followed by visco-device aspiration and wound seal via an irrigation-port hydration technique formulated to stabilize the anterior chamber and limit immediate blood reflux.
Surgical success was systematically assessed at six months postoperatively using three progressively stringent intraocular pressure benchmarks. Qualified success, which permitted continued use of postoperative antiglaucoma medications but precluded additional glaucoma operations or loss of light perception, required intraocular pressure to fall within specified ranges: criterion A set the target between 6 and 18 millimeters of mercury, criterion B required pressure between 6 and 15 millimeters of mercury, and criterion C enforced a strict range between 6 and 13 millimeters of mercury. For the entire cohort of sixty-seven eyes, the cumulative probability of qualified success reached 94.0 percent under criterion A, 82.1 percent under criterion B, and 60.0 percent under criterion C. Surgical failures were triggered entirely by intraocular pressure exceeding upper thresholds on two consecutive follow-up visits, managed by reinstating topical medications, with only one eye eventually progressing to secondary trabeculectomy.
To assess the specific influence of patient age, the investigators divided the cohort into two groups based on the median cohort age of seventy-six years. The younger group comprised thirty-two patients with a mean age of 68.0 years, while the older group included thirty-five patients with a mean age of 82.5 years. Baseline demographic and clinical parameters—including systemic hypertension, diabetes mellitus, hyperlipidemia, asthma, antithrombotic therapy use, best-corrected visual acuity, and baseline visual field mean deviation—showed no statistically significant differences between the two age groups. However, the younger cohort presented with a significantly higher mean preoperative glaucoma medication score of 2.6 compared to 1.7 in the older cohort, indicating that younger individuals entered surgery with a heavier pharmacologic burden or potentially more treatment-resistant disease.
Kaplan–Meier survival analysis demonstrated comparable surgical outcomes between groups under liberal pressure criteria, alongside an apparent advantage for older patients under tighter boundaries. For criterion A, the six-month cumulative qualified success probability was 90.6 percent in the younger cohort and 97.1 percent in the older cohort, showing no statistically significant variation. Under criterion B, success rates stood at 75.0 percent and 88.6 percent, respectively. Under the strictest standard, criterion C, the cumulative qualified success probability reached 71.4 percent among older patients compared to 46.9 percent in younger patients, yielding a nominal statistically significant difference with a p-value of 0.04. When restricted to primary open-angle glaucoma eyes, success under criterion C was 74.1 percent in older eyes and 51.9 percent in younger eyes, though this subgroup comparison did not retain statistical significance.
Analysis of postoperative intraocular pressure dynamics demonstrated consistent pressure reduction across both cohorts, with older patients sustaining lower absolute pressure readings from week two through month six. At postoperative month six, mean absolute intraocular pressure reduction from baseline measured 2.2 millimeters of mercury in the younger group and 2.9 millimeters of mercury in the older group, translating to mean proportional decreases of 12.9 percent and 17.5 percent, respectively. Concurrently, the older group maintained lower postoperative glaucoma medication scores and achieved higher complete success rates—defined as achieving target pressure levels without any supplemental glaucoma medications throughout the six months. Under criterion C, forty-six percent of older eyes attained complete success compared with nine percent of younger eyes, while sixty percent of older patients were completely free of pressure-lowering drops at month six compared to thirty-nine percent in the younger tier.
Despite the apparent advantages observed in unadjusted group comparisons, multivariable Cox proportional hazards regression models revealed that age itself was not an independent predictor of surgical failure. Instead, independent factors predicting surgical failure included elevated baseline intraocular pressure under both criterion B and criterion C, alongside systemic hypertension under criterion B and antithrombotic therapy under criterion C. The hazard ratio for failure associated with higher baseline intraocular pressure was 1.33 under criterion B and 1.20 under criterion C. Hypertension doubled the risk of failure under criterion B with a hazard ratio of 2.09, while antithrombotic therapy yielded a hazard ratio of 2.21 under criterion C. The authors observed that the initial disparity in baseline eye-drop use between groups likely contributed to the unadjusted differences, as prolonged topical therapy exposure can induce conjunctival and trabecular remodeling.
Safety outcomes indicated that advanced chronological age did not introduce excess surgical risk or structural complications. Postoperative hyphema scores, measured via the standardized Shimane University red blood cell-layer-clot scale, showed comparable resolution between groups, with blood clearing promptly and slightly higher scores noted on postoperative day one in younger patients. Transient postoperative intraocular pressure spikes above ten millimeters of mercury occurred at similar frequencies across groups, and corneal endothelial cell density losses at one month were nearly identical, exhibiting reductions of 4.7 percent in younger patients and 4.2 percent in older patients. No eye experienced prolonged hypotony, choroidal detachment, or loss of light perception. Postoperative systemic complications were rare and typical for older surgical populations, reinforcing the conclusion that microhook ab interno trabeculotomy combined with phacoemulsification represents a safe, viable intervention for elderly glaucoma patients needing concurrent cataract extraction.
Subject of Research: Microhook ab interno trabeculotomy combined with cataract surgery in older glaucoma patients
Article Title: Safety and Efficacy of Microhook Ab Interno Trabeculotomy Combined with Cataract Surgery in Older Patients with Glaucoma
Article References: Ebisutani, S., Noro, T., Yamada, Y., & Kitaoka, Y. (2026). Safety and Efficacy of Microhook Ab Interno Trabeculotomy Combined with Cataract Surgery in Older Patients with Glaucoma. Ophthalmology and Therapy. https://doi.org/10.1007/s40123-026-01529-4
Image Credits: AI Generated
DOI: 10.1007/s40123-026-01529-4
Keywords: glaucoma, cataract surgery, minimally invasive glaucoma surgery, microhook ab interno trabeculotomy, intraocular pressure, ophthalmology, trabecular meshwork, Schlemm’s canal, phacoemulsification, geriatric ophthalmology, hyphema, corneal endothelial cell loss, primary open-angle glaucoma, ocular hypertension, antithrombotic therapy, topical glaucoma medication
